PAICS expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.721620E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.714850E-01
Normal-vs-Stage2
6.247600E-04
Normal-vs-Stage3
5.014200E-01
Normal-vs-Stage4
8.398400E-02
Stage1-vs-Stage2
8.514400E-01
Stage1-vs-Stage3
6.729200E-01
Stage1-vs-Stage4
6.231000E-01
Stage2-vs-Stage3
5.160200E-01
Stage2-vs-Stage4
6.938200E-01
Stage3-vs-Stage4
3.671200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.829900E-04
Normal-vs-AfricanAmerican
2.763600E-01
Normal-vs-Asian
2.973000E-01
Caucasian-vs-AfricanAmerican
7.759600E-01
Caucasian-vs-Asian
1.593770E-02
AfricanAmerican-vs-Asian
3.447800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.195600E-04
Normal-vs-Female
1.033460E-04
Male-vs-Female
3.836600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.249800E-01
Normal-vs-Age(41-60Yrs)
7.88150000000654E-05
Normal-vs-Age(61-80Yrs)
8.415500E-04
Normal-vs-Age(81-100Yrs)
1.967890E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.471800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.442200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.946180E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.512200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.054600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.445400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.431910E-02
Normal-vs-Daily Drinker
2.786300E-02
Normal-vs-Weekly Drinker
5.147700E-02
Normal-vs-Occasional Drinker
5.520000E-02
Normal-vs-Social Drinker
1.076350E-01
Non Drinker-vs-Daily Drinker
7.017200E-01
Non Drinker-vs-Weekly Drinker
6.653800E-01
Non Drinker-vs-Occasional Drinker
4.996800E-01
Non Drinker-vs-Social Drinker
7.563400E-01
Daily Drinker-vs-Weekly Drinker
4.408000E-01
Daily Drinker-vs-Occasional Drinker
2.479400E-01
Daily Drinker-vs-Social Drinker
4.632000E-01
Weekly Drinker-vs-Occasional Drinker
9.851200E-01
Weekly Drinker-vs-Social Drinker
8.309400E-01
Occasional Drinker-vs-Social Drinker
6.906400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.936600E-01
Normal-vs-Grade 2
7.657200E-01
Normal-vs-Grade 3
8.455400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.703910E-02
Grade 1-vs-Grade 3
7.558300E-04
Grade 1-vs-Grade 4
6.936600E-01
Grade 2-vs-Grade 3
5.373900E-02
Grade 2-vs-Grade 4
7.657200E-01
Grade 3-vs-Grade 4
8.455400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.594400E-01
Normal-vs-NonDiabetic
2.780000E-04
Diabetic-vs-NonDiabetic
1.205050E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.256850E-01
Normal-vs-NoPancreatitis
5.996900E-04
Pancreatitis-vs-NoPancreatitis
7.948000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.264830E-01
Normal-vs-N1
3.031900E-04
N0-vs-N1
7.240600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.01259997556491E-09
Normal-vs-TP53-NonMutant
3.081200E-03
TP53-Mutant-vs-TP53-NonMutant
5.22759999954658E-07
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
